739 related articles for article (PubMed ID: 32430627)
1. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.
Moccia F; Gerbino A; Lionetti V; Miragoli M; Munaron LM; Pagliaro P; Pasqua T; Penna C; Rocca C; Samaja M; Angelone T
Geroscience; 2020 Aug; 42(4):1021-1049. PubMed ID: 32430627
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.
Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J
Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and the Heart.
Rojulpote C; Gonuguntla K; Patil S; Bhattaru A; Bravo PE
Colomb Med (Cali); 2020 Jun; 51(2):e4320. PubMed ID: 33012891
[TBL] [Abstract][Full Text] [Related]
4. Potential Effects of Coronaviruses on the Cardiovascular System: A Review.
Madjid M; Safavi-Naeini P; Solomon SD; Vardeny O
JAMA Cardiol; 2020 Jul; 5(7):831-840. PubMed ID: 32219363
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular system and COVID-19: manifestations and therapeutics.
Mahenthiran AK; Mahenthiran AK; Mahenthiran J
Rev Cardiovasc Med; 2020 Sep; 21(3):399-409. PubMed ID: 33070544
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar.
Giustino G; Pinney SP; Lala A; Reddy VY; Johnston-Cox HA; Mechanick JI; Halperin JL; Fuster V
J Am Coll Cardiol; 2020 Oct; 76(17):2011-2023. PubMed ID: 33092737
[TBL] [Abstract][Full Text] [Related]
7. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.
Yang C; Jin Z
JAMA Cardiol; 2020 Jul; 5(7):743-744. PubMed ID: 32211809
[No Abstract] [Full Text] [Related]
8. Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.
Wessler BS; Kent DM; Konstam MA
JAMA Cardiol; 2020 Sep; 5(9):981-982. PubMed ID: 32936280
[No Abstract] [Full Text] [Related]
9. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.
Linschoten M; Asselbergs FW
Eur Heart J; 2020 May; 41(19):1795-1796. PubMed ID: 32267494
[No Abstract] [Full Text] [Related]
10. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.
Dhakal BP; Sweitzer NK; Indik JH; Acharya D; William P
Heart Lung Circ; 2020 Jul; 29(7):973-987. PubMed ID: 32601020
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.
Geng YJ; Wei ZY; Qian HY; Huang J; Lodato R; Castriotta RJ
Cardiovasc Pathol; 2020; 47():107228. PubMed ID: 32375085
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and the heart: An update for clinicians.
Goha A; Mezue K; Edwards P; Nunura F; Baugh D; Madu E
Clin Cardiol; 2020 Nov; 43(11):1216-1222. PubMed ID: 32533585
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, prognosis, and clinical manifestation of cardiovascular disease in COVID-19.
Capone V; Cuomo V; Esposito R; Canonico ME; Ilardi F; Prastaro M; Esposito G; Santoro C
Expert Rev Cardiovasc Ther; 2020 Aug; 18(8):531-539. PubMed ID: 32672482
[TBL] [Abstract][Full Text] [Related]
16. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
Prezioso C; Marcocci ME; Palamara AT; De Chiara G; Pietropaolo V
J Neurovirol; 2020 Jun; 26(3):311-323. PubMed ID: 32548750
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and COVID-19.
Bansal M
Diabetes Metab Syndr; 2020; 14(3):247-250. PubMed ID: 32247212
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and the cardiovascular system.
Hafiane A
Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
Krittanawong C; Virk HUH; Narasimhan B; Wang Z; Narasimhan H; Zhang HJ; Sun T; Messerli FH
Prog Cardiovasc Dis; 2020; 63(4):527-528. PubMed ID: 32389584
[No Abstract] [Full Text] [Related]
20. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
